Pathogenesis of ankylosing spondylitis
- PMID: 20517295
- DOI: 10.1038/nrrheum.2010.79
Pathogenesis of ankylosing spondylitis
Abstract
Ankylosing spondylitis (AS) is a potentially disabling form of seronegative spondyloarthritis. The main symptom of AS is inflammatory spinal pain; with time, some patients develop ankylosis and spinal immobility. The pathology mainly affects the entheses, where ligaments, tendons and capsules are attached to the bone. Three processes are observed at the entheses: inflammation, bone erosion and syndesmophyte (spur) formation. Tumor necrosis factor is an important mediator of the inflammatory processes, but this proinflammatory cytokine is not closely involved in bone erosion or syndesmophyte formation. The major causative factors of AS are genetic, with the gene encoding HLA-B27 being the most important genetic factor. Several other susceptibility genes have also been identified. An enormous number of papers have been published and many diverse hypotheses have been generated regarding the pathogenesis of AS. This Review outlines the key areas of current research in this field, describes several hypotheses regarding the pathogenesis of AS, which are under intense investigation, and concludes with a dissection of the processes involved in bone erosion and syndesmophyte formation.
Similar articles
-
[Some aspects of pathogenesis of ankylosing spondylitis].Ter Arkh. 2011;83(5):51-6. Ter Arkh. 2011. PMID: 21780658 Review. Russian.
-
Genetic susceptibility to ankylosing spondylitis.Curr Mol Med. 2004 Feb;4(1):13-20. doi: 10.2174/1566524043479284. Curr Mol Med. 2004. PMID: 15011955 Review.
-
Pathogenesis of ankylosing spondylitis: current concepts.Best Pract Res Clin Rheumatol. 2006 Jun;20(3):571-91. doi: 10.1016/j.berh.2006.03.001. Best Pract Res Clin Rheumatol. 2006. PMID: 16777583 Review.
-
[Pathogenesis of ankylosing spondylitis-mechanisms of disease manifestation and chronicity].Z Rheumatol. 2004 Jun;63(3):187-92. doi: 10.1007/s00393-004-0628-x. Z Rheumatol. 2004. PMID: 15224221 Review. German.
-
A review of the pathogenesis of ankylosing spondylitis.Neurosurg Focus. 2008;24(1):E2. doi: 10.3171/FOC/2008/24/1/E2. Neurosurg Focus. 2008. PMID: 18290740 Review.
Cited by
-
The Retention Rate and Safety of Secukinumab as a First-Line Biologic Agent in Axial Spondyloarthritis Compared to a First Tumor Necrosis Factor (TNF) Inhibitor: A Real-World, Longitudinal Study.Cureus. 2024 Sep 28;16(9):e70365. doi: 10.7759/cureus.70365. eCollection 2024 Sep. Cureus. 2024. PMID: 39469413 Free PMC article.
-
The Development of Extra-Articular Manifestations in Children With Enthesitis-Related Arthritis: Natural Course or Different Disease Entity?Front Med (Lausanne). 2021 May 13;8:667305. doi: 10.3389/fmed.2021.667305. eCollection 2021. Front Med (Lausanne). 2021. PMID: 34055840 Free PMC article.
-
Characterization of the recognition specificity of BH2, a monoclonal antibody prepared against the HLA-B27 heavy chain.Int J Mol Sci. 2015 Apr 13;16(4):8142-50. doi: 10.3390/ijms16048142. Int J Mol Sci. 2015. PMID: 25872138 Free PMC article.
-
MEG3 alleviates ankylosing spondylitis by suppressing osteogenic differentiation of mesenchymal stem cells through regulating microRNA-125a-5p-mediated TNFAIP3.Apoptosis. 2023 Apr;28(3-4):498-513. doi: 10.1007/s10495-022-01804-2. Epub 2022 Dec 31. Apoptosis. 2023. PMID: 36587050
-
Targeted delivery of an antigenic peptide to the endoplasmic reticulum: application for development of a peptide therapy for ankylosing spondylitis.PLoS One. 2013 Oct 14;8(10):e77451. doi: 10.1371/journal.pone.0077451. eCollection 2013. PLoS One. 2013. PMID: 24155957 Free PMC article.
References
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Research Materials